An in-depth look to BIOCURE TECHNOLOGY INC. operating, investing, and financing activities

CURE.X free cash flow for Q2 24 is 25.26 k CAD. For 2023, CURE.X free cash flow was -217.13 k CAD and operating cash flow was -217.13 k CAD.